Related Experiment Video
Updated: Jun 13, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
The association between klotho and kidney and cardiovascular outcomes: a comprehensive systematic review and
Mehmet Kanbay1, Crischentian Brinza2,3, Lasin Ozbek4
1Department of Medicine, Division of Nephrology, Koç University School of Medicine, Istanbul, Turkey.
Insights
Lower klotho levels in chronic kidney disease (CKD) patients predict higher mortality and adverse renal events. This finding highlights klotho as a key prognostic marker for kidney disease progression and patient outcomes.
Area of Science:
- Nephrology
- Biomarkers
- Chronic Disease Management
Background:
- Chronic kidney disease (CKD) and end-stage renal disease (ESKD) present significant global health challenges.
- These conditions are linked to progressive kidney dysfunction, cardiovascular disease, and increased mortality.
- Investigating prognostic markers is crucial for managing CKD and ESKD patients.
Purpose of the Study:
- To explore the association between plasma klotho levels and prognostic outcomes in CKD and ESKD patients.
- To evaluate klotho's role in predicting all-cause mortality, cardiovascular events, and adverse renal events.
- To assess the relationship between klotho levels and the need for renal replacement therapies.
Main Methods:
- A systematic literature review was conducted using major electronic databases (PubMed, MEDLINE, Web of Science, etc.).
- The review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- Fourteen studies were included in the analysis.
Main Results:
- Lower klotho levels were significantly associated with increased all-cause mortality (OR 1.81) and cardiovascular mortality (OR 2.11).
- Patients with low klotho showed a higher risk of adverse renal events (OR 2.36) and progression to ESKD or kidney replacement therapy (OR 2.30).
- While composite cardiovascular events did not show a significant difference, heterogeneity was high.
Conclusions:
- Reduced serum klotho levels are a significant predictor of adverse outcomes in CKD patients.
- Low klotho is associated with increased risks of mortality and progression to end-stage kidney disease.
- Klotho may serve as a valuable prognostic biomarker in the management of kidney disease.
Background:
Chronic kidney disease (CKD) and end-stage renal disease (ESKD) are significant global health challenges associated with progressive kidney dysfunction and numerous complications, including cardiovascular disease and mortality. This study aims to explore the potential association between plasma klotho levels and various prognostic outcomes in CKD and ESKD, including all-cause mortality, cardiovascular events, metabolic syndrome development and adverse renal events necessitating renal replacement therapies.
Methods:
A literature search was conducted through 3 June 2024 using the electronic databases Cochrane Library, Ovid MEDLINE, CINAHL, Web of Science, SCOPUS and PubMed. This systematic review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results:
Fourteen studies were included. For all-cause mortality, comparing CKD patients with low versus high klotho levels showed a significant association {odds ratio [OR] 1.81 [95% confidence interval (CI) 1.34-2.44], P = .0001}, with substantial heterogeneity (I 2 = 69%). Excluding one study reduced heterogeneity (I 2 = 43%) while maintaining significance [OR 1.97 (95% CI 1.45-2.66), P < .0001]. Cardiovascular mortality was higher in patients with low klotho levels [OR 2.11 (95% CI 1.61-2.76), P < .00001], with low heterogeneity (I 2 = 25%). Excluding one study eliminated heterogeneity (I 2 = 0%) while maintaining significance [OR 2.39 (95% CI 1.83-3.12), P < .00001]. Composite cardiovascular events did not differ significantly between low and high klotho groups [OR 1.51 (95% CI 0.82-2.77), P = .18], but with high heterogeneity (I 2 = 72%). Patients with low klotho levels had a higher risk of adverse renal events [OR 2.36 (95% CI 1.37-4.08), P = .002], with moderate heterogeneity (I 2 = 61%). Sensitivity analysis reduced heterogeneity (I 2 = 0%) while maintaining significance [OR 3.08 (95% CI 1.96-4.85), P < .00001]. Specifically, for ESKD or kidney replacement therapy risk, low klotho levels were associated with an increased risk [OR 2.30 (95% CI 1.26-4.21), P = .007]. Similarly, CKD progression risk was higher in patients with lower klotho levels [OR 2.48 (95% CI 1.45-4.23), P = .0009].
Conclusion:
Lower serum klotho levels serve as a significant predictor of adverse outcomes, including increased risks of all-cause mortality, cardiovascular mortality and progression to end-stage kidney disease among CKD patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Heart Failure Drugs: Diuretics
Internal Anatomy of the Kidney
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...
Overview of the Vascular System
Antihypertensive Drugs: Potassium-Sparing Diuretics

